CompletedNCT02013531
Official study titleProtocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
This study has finished and is no longer accepting participants.
Multiple locations, including TusconDepression, AnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT06001346
Official study titleActiveCBT for Depression: Transforming Treatment Through Exercise Priming
This study has finished and is no longer accepting participants.
In AmesDepressionBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
CompletedNCT00285935
Official study titleNeurosteroid Metabolism and the Antidepressant Effects of Serotonin Specific Reuptake Inhibitors (SSRI's)
This study has finished and is no longer accepting participants.
In San FranciscoDepressionInterventional studyAges 21–60
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT04939818
Official study titleA Study to Investigate the Feasibility of Administration of a Speech Battery and the Use of Speech-based Biomarkers for the Clinical Assessment of Common Neurodegenerative and Psychiatric Disorders in a Remote Setting.
This study has finished and is no longer accepting participants.
In LondonDepression, BipolarityObservational studyAges 18–85
- Countries
- United Kingdom
- Sponsor
- Novoic Limited
Active Not RecruitingNCT07085143
What is this study about?Researchers are comparing Compound Ciwujia Granules and placebo to find out how the approaches affect depression symptoms in people with depression.
This study is no longer accepting new participants.
In ShanghaiDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
CompletedNCT04985942
What is this study about?This study evaluated the safety and effectiveness of Lumateperone for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixDepressionMedication studyAges 18–65
- Countries
- United States, Bulgaria, Czechia, + 3 others
- Sponsor
- Intra-Cellular Therapies, Inc.
CompletedNCT04142320
Official study titleRandomized, Cross-over, Placebo-controlled Trial to Determine Target Engagement and Dose Response of Optimized Closed-loop rTMS for Medication-resistant Depression
This study has finished and is no longer accepting participants.
In StanfordDepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT05772702
Official study titleClosed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression (CLACS): Single-Site Open-Label Pilot Study
This study has finished and is no longer accepting participants.
In Chapel HillDepressionDevice studyAges 18–70
- Countries
- United States
- Sponsor
- Electromedical Products International, Inc.
CompletedNCT02860910
Official study titleCross-Cultural Cognitive Behavioral Group Therapy: Evaluating the Effectiveness of a Manualized Cognitive Behavior Group Therapy Treatment for the Management of Menopause Symptoms in a Mood and Anxiety Disorder Population
This study has finished and is no longer accepting participants.
In ClevelandDepression, BipolarityBehavioural studyAges 40–65
- Countries
- United States
- Sponsor
- Danette Conklin, PhD
CompletedNCT06775054
Official study titleThe Role of Cognitive Flexibility in Depression and Response to Transcranial Magnetic Stimulation (TMS)
This study has finished and is no longer accepting participants.
In AnkaraDepressionDevice studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Gulhane Training and Research Hospital
CompletedNCT02502604
Official study titleInvestigating the Efficacy of a Top-Down Approach to Cognitive Remediation in Individuals With Affective Disorders
This study has finished and is no longer accepting participants.
In HamiltonDepression, PTSDBehavioural studyAges 18–60
- Countries
- Canada
- Sponsor
- St. Joseph's Healthcare Hamilton
